Patheon eyes wins in wake of FDA warnings to Big Pharma
The surge in FDA cGMP warning letters to major biopharma companies has created an opportunity for CMOs, the CEO of Patheon said.
Archives for June 20, 2012
News from BioAlliance, Cangene and Sucampo – People on the move
in-PharmaTechnologist.com presents its weekly round-up of the latest comings and goings in the pharma industry, including news from BioAlliance, Cangene and Sucampo.
Is drug delivery by skin the solution to bioavailability woes? report from Achema
Drug regulators and the biomanufacturing industry need to embrace drug delivery via the skin to solve solubility problems with peptides and proteins, according to Across Barriers’ Udo Bock.
Price of water & corporate sustainability agendas pushing waste reuse; Veolia
The price of water and corporate agendas are driving pharmaceutical production plants to reuse and reclaim waste, Veolia said.
UPDATE
Quintiles boosts lab testing in China
Quintiles has teamed up with the Shanghai Clinical Research Centre (SCRC) to ramp-up its biopharmaceutical lab testing services in China.
Apricus Biosciences buying CSO to support European sales push
Apricus Biosciences is to buy a French contract sales and marketing firm to support its activities in Europe.
West and Amgen sign Crystal Zenith evaluation deal
West Pharmaceutical Services has inked a deal with Amgen to evaluate its Crystal Zenith technology for drug containment.